Specific Induction of Tumor Neovasculature Death by Modified Murine PPE-1 Promoter Armed with HSV-TK | Zendy

Nira VardaBloom | Zendy; Israel Hodish | Zendy; Aviv Shaish | Zendy; Shoshana Greenberger | Zendy; Reshef Tal | Zendy; Bela Feder | Zendy; Joseph Roitelman | Zendy; Eyal Breitbart | Zendy; Livnat Bangio | Zendy; Iris Barshack | Zendy; Raphael Pfeffer | Zendy; Dror Harats | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Specific Induction of Tumor Neovasculature Death by Modified Murine PPE-1 Promoter Armed with HSV-TK

Author(s) -

Nira VardaBloom,

Israel Hodish,

Aviv Shaish,

Shoshana Greenberger,

Reshef Tal,

Bela Feder,

Joseph Roitelman,

Eyal Breitbart,

Livnat Bangio,

Iris Barshack,

Raphael Pfeffer,

Dror Harats

Publication year - 2008

Publication title -

pathobiology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.941

H-Index - 53

eISSN - 1423-0291

pISSN - 1015-2008

DOI - 10.1159/000164219

Subject(s) - cancer research , angiogenesis , lewis lung carcinoma , promoter , microbiology and biotechnology , in vivo , metastasis , reporter gene , genetic enhancement , biology , thymidine kinase , viral vector , herpes simplex virus , gene expression , immunology , gene , cancer , virus , recombinant dna , biochemistry , genetics

One strategy to increase tissue specificity of gene therapy is to use promoters or enhancers.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research